Cabaletta Bio, Inc.
CABA • NASDAQ
Cabaletta Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven A. Nichtberger, with a market cap of $352.9M.
Market Cap$352.9M
Employees120.0
CEOSteven A. Nichtberger
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Cabaletta Bio, Inc. FAQ
Common questions about Cabaletta Bio, Inc.
Cabaletta Bio, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026.
Cabaletta Bio, Inc. has approximately 120 employees.